- Investing Ideas
- Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Results
15
Companies with a Future performance score of at least 3, ordered by Future performance score.
15 companies
Kuros Biosciences
Market Cap: CHF 813.2m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 20.62
7D
-3.4%
1Y
-16.5%
Newron Pharmaceuticals
Market Cap: CHF 244.2m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 12.20
7D
-10.4%
1Y
58.4%
SKAN Group
Market Cap: CHF 1.1b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 50.80
7D
2.4%
1Y
-32.4%
MindMaze Therapeutics Holding
Market Cap: CHF 52.5m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.34
7D
-7.9%
1Y
n/a
Dottikon ES Holding
Market Cap: CHF 4.1b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia.
DESN
CHF 295.00
7D
-4.8%
1Y
7.5%
Cosmo
Market Cap: CHF 1.2b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 72.80
7D
-6.7%
1Y
20.9%
Idorsia
Market Cap: CHF 1.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 4.30
7D
-3.8%
1Y
113.3%
Galderma Group
Market Cap: CHF 37.9b
Operates as a dermatology company worldwide.
GALD
CHF 161.50
7D
-3.0%
1Y
39.3%
PolyPeptide Group
Market Cap: CHF 1.2b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 36.40
7D
-4.0%
1Y
70.1%
Tecan Group
Market Cap: CHF 2.0b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 156.50
7D
0.7%
1Y
-4.5%
Novartis
Market Cap: CHF 216.0b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 117.98
7D
0.1%
1Y
21.5%
Sandoz Group
Market Cap: CHF 27.9b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 64.40
7D
-1.8%
1Y
46.3%
Bachem Holding
Market Cap: CHF 5.1b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 68.55
7D
-10.8%
1Y
27.1%
Lonza Group
Market Cap: CHF 33.9b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 485.60
7D
-3.0%
1Y
-15.3%
Molecular Partners
Market Cap: CHF 112.5m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.00
7D
-4.5%
1Y
0.3%